Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
eli lilly
indiana blog main
indiana top stories
3
×
life sciences
national blog main
amgen
boston blog main
boston top stories
calcitonin gene-related peptide
chronic migraine
clinical trials
episodic migraine
fda
national top stories
novartis
san francisco blog main
san francisco top stories
teva pharmaceutical
alder biopharmaceuticals
avapritinib
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
cancer
cancer drugs
capmatinib
david rind
detroit blog main
detroit top stories
drugs
eptinezumab
erenumab
europe blog main
europe top stories
food and drug administration
fremanezumab
galcanezumab
gastrointestinal stromal tumors
What
approval
3
×
drug
fda
medicines
3
×
class
developed
migraine
new
pain
starts
won
address
amgen
announced
approved
approves
blueprint
cancer
candidates
carries
certain
decision
designed
eli
genetic
gets
head
headache
late
latest
lilly
marks
nod
pass
prevent
preventive
ret
signature
signatures
targeted
Language
unset
Current search:
medicines
×
approval
×
" indiana top stories "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines